Oculis Holding AG
OCS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $322.0M in total; no superinvestor holds it.
Other share classesOCSAW
13F holders, Q2 2026
Institutional positions in Oculis Holding AG as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- +3 vs. Q1 2026
- Shares held
- 23.2M
- +5.52M (+31.2%) vs. Q1 2026
- Total value
- $322.0M
- −$148.4M (−31.5%) vs. Q1 2026
- New holders
- 21
- 23 more added
- Sold out
- 18
- 9 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $322.0M |
| Q1 2026 | 57 | $534.7M |
| Q4 2025 | 41 | $363.8M |
| Q3 2025 | 20 | $191.7M |
| Q2 2025 | 23 | $99.1M |
| Q1 2025 | 20 | $94.7M |
| Q4 2024 | 12 | $59.4M |
| Q3 2024 | 10 | $36.9M |
| Q2 2024 | 11 | $39.8M |
| Q1 2024 | 9 | $40.9M |
| Q4 2023 | 7 | $44.3M |
| Q3 2023 | 9 | $32.1M |
| Q2 2023 | 9 | $38.5M |
| Q1 2023 | 7 | $23.2M |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Oculis Holding AG; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DuPont Capital Management Corp | 4 | $55 | 0.00% | 00.0% | Unchanged |
| Stone House Investment Management, LLC | 8 | $111 | 0.00% | +8 | New |
| Royal Bank of Canada | 79 | $1.00K | 0.00% | +14+21.5% | Added |
| Citigroup Inc | 76 | $1.05K | 0.00% | +75+7,500.0% | Added |
| Larson Financial Group LLC | 83 | $1.15K | 0.00% | +83 | New |
| Advisor Group Holdings, Inc. | 102 | $1.42K | 0.00% | +102 | New |
| Jones Financial Companies LLLP | 210 | $2.52K | 0.00% | 00.0% | Unchanged |
| SHP Wealth Management | 756 | $10.5K | 0.00% | +756 | New |
| Group One Trading, L.P. | 2,400 | $33.3K | 0.00% | +2,400 | New |
| Wolverine Asset Management LLC | 2,975 | $41.3K | 0.00% | +2,975 | New |
| Barclays PLC | 3,237 | $44.9K | 0.00% | +3,237 | New |
| Aventura Private Wealth, LLC | 4,000 | $55.5K | 0.02% | 00.0% | Unchanged |
| Quantbot Technologies LP | 5,319 | $73.8K | 0.00% | +5,319 | New |
| Jane Street Group, LLC | 11,258 | $156.1K | 0.00% | −78,903−87.5% | Reduced |
| Susquehanna International Group, LLP | 12,331 | $171.0K | 0.00% | +12,331 | New |
| Marble Bar Asset Management LLP | 14,806 | $205.4K | 0.14% | +14,806 | New |
| Himension Fund | 17,276 | $239.6K | 0.01% | −1,650−8.7% | Reduced |
| Northern Trust Corp | 20,623 | $286.0K | 0.00% | −566−2.7% | Reduced |
| JPMorgan Chase & Co | 24,846 | $325.2K | 0.00% | −28,199−53.2% | Reduced |
| State Street Corp | 23,577 | $327.0K | 0.00% | +4,577+24.1% | Added |
| Persistent Asset Partners Ltd | 25,604 | $355.1K | 0.11% | +25,604 | New |
| Virtus Investment Advisers, Inc. | 29,504 | $409.2K | 0.10% | +29,504 | New |
| Tudor Investment Corp Et Al | 31,021 | $430.3K | 0.00% | +2,127+7.4% | Added |
| Jump Financial, LLC | 39,733 | $551.1K | 0.00% | +39,733 | New |
| XTX Topco Ltd | 43,096 | $597.7K | 0.01% | +20,073+87.2% | Added |
| Bank of America Corp | 43,978 | $610.0K | 0.00% | −25,786−37.0% | Reduced |
| Boothbay Fund Management, LLC | 56,391 | $782.1K | 0.01% | +31,431+125.9% | Added |
| Alps Advisors Inc | 58,019 | $804.7K | 0.00% | +11,480+24.7% | Added |
| Geode Capital Management, LLC | 61,224 | $849.2K | 0.00% | +2,299+3.9% | Added |
| Squarepoint Ops LLC | 61,605 | $854.5K | 0.00% | +47,158+326.4% | Added |
| Balyasny Asset Management LLC | 65,608 | $910.0K | 0.00% | +65,608 | New |
| Goldman Sachs Group Inc | 69,502 | $964.0K | 0.00% | +1,749+2.6% | Added |
| Compagnie Lombard Odier SCmA | 105,455 | $1.46M | 0.02% | 00.0% | Unchanged |
| Trexquant Investment LP | 151,228 | $2.10M | 0.01% | +106,990+241.9% | Added |
| UBS Group AG | 182,415 | $2.53M | 0.00% | +119,669+190.7% | Added |
| Y-Intercept (Hong Kong) Ltd | 192,016 | $2.66M | 0.05% | +162,819+557.7% | Added |
| Woodline Partners LP | 201,200 | $2.79M | 0.01% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 206,332 | $2.86M | 0.01% | −125,000−37.7% | Reduced |
| Point72 Asset Management, L.P. | 220,403 | $3.06M | 0.00% | +164,276+292.7% | Added |
| Morgan Stanley | 225,083 | $3.12M | 0.00% | +158,846+239.8% | Added |
| Qube Research & Technologies Ltd | 262,113 | $3.64M | 0.00% | +241,623+1,179.2% | Added |
| Nan Fung Group Holdings Ltd | 300,565 | $4.17M | 3.17% | −50,180−14.3% | Reduced |
| Syquant Capital SAS | 375,000 | $5.20M | 1.16% | +152,133+68.3% | Added |
| Marshall Wace, LLP | 394,880 | $5.48M | 0.00% | +394,880 | New |
| Manufacturers Life Insurance Company, The | 398,980 | $5.53M | 0.00% | +398,980 | New |
| Franklin Resources Inc | 434,751 | $6.03M | 0.00% | +434,751 | New |
| PFM Health Sciences, LP | 436,042 | $6.05M | 0.53% | +436,042 | New |
| Wellington Management Group LLP | 540,056 | $7.49M | 0.00% | −805,672−59.9% | Reduced |
| Ameriprise Financial Inc | 619,922 | $8.60M | 0.00% | +619,922 | New |
| Siren, L.L.C. | 625,000 | $8.67M | 0.18% | +625,000 | New |
| Sr One Capital Management, LP | 641,022 | $8.89M | 0.86% | 00.0% | Unchanged |
| Saturn V Capital Management LLC | 684,880 | $9.50M | 1.36% | +168,119+32.5% | Added |
| Perceptive Advisors LLC | 808,827 | $11.2M | 0.17% | +315,000+63.8% | Added |
| Braidwell LP | 834,183 | $11.6M | 0.43% | +834,183 | New |
| Citadel Advisors LLC | 987,204 | $13.7M | 0.01% | +825,920+512.1% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,506,250 | $20.9M | 6.79% | −174,033−10.4% | Reduced |
| Millennium Management LLC | 2,042,467 | $28.3M | 0.02% | +1,129,433+123.7% | Added |
| Standard Life Aberdeen plc | 2,159,809 | $30.0M | 0.04% | +412,863+23.6% | Added |
| EQT Fund Management S.a r.l. | 6,950,294 | $96.4M | 11.18% | +1,050,000+17.8% | Added |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −833,209−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −430,000−100.0% | Sold out |
| Folketrygdfondet | 0 | $0 | 0.00% | −319,556−100.0% | Sold out |
| NEXTBio Capital Management LP | 0 | $0 | 0.00% | −149,592−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −148,021−100.0% | Sold out |
| Propel Bio Management, LLC | 0 | $0 | 0.00% | −122,223−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −98,339−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −66,667−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −25,482−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −18,145−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −14,118−100.0% | Sold out |
| Palumbo Wealth Management LLC | 0 | $0 | 0.00% | −13,711−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −8,937−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −8,524−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −5,050−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −540−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −252−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −222−100.0% | Sold out |
| Gildi - lifeyrissjodur | – | – | – | – | Not filed |